Retinopathy Of Prematurity (Ophthalmology) Drugs Pipeline Report 2021 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Retinopathy Of Prematurity (Ophthalmology) - Drugs In Development, 2021" report has been added to ResearchAndMarkets.com's offering. The report provides an overview of the Retinopathy Of Prematurity (Ophthalmology) pipeline landscape. Retinopathy of prematurity (ROP) is a disease that affects immature vasculature in the eyes of premature babies. This disorder which usually develops in both eyes is one of the most common causes of visual loss in childhood and can le

Full Story →